InvestorsHub Logo
Followers 483
Posts 61598
Boards Moderated 14
Alias Born 09/20/2001

Re: XenaLives post# 188530

Wednesday, 04/10/2019 8:11:04 AM

Wednesday, April 10, 2019 8:11:04 AM

Post# of 469773
Historical discussion of Aisen & the ACTC..

I had some errors in the replied post so this is a correction.

With Aisen on the SAB it would be kind of hard for Anavex to not be on the ACTC's radar.

PR appointing Aisen to SAB in 2011:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147411285

Other Aisen Board links:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147360088
Aisen and the ACTC:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147409548
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147409564


Historical discussion on Aisen:


The simplest explanation for why Australian sites are up and running and the North American ones aren't... The sites aren't ready and the Anavex 2-73 precision medicine trial requires more efficiency than the U.S. system can currently provide.


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145449081



Chairman of the NIH/ACTC is Dr Paul Aisen MD he joined Anavex SAB in 2011 and is still a member.
Now what are the chances that A2-73 will be included in the ACTC?
What are the chances that this is why no N American sites for the latest A2-73 trial have been announced yet?
For those preoccupied with current share price of AVXL, how big a catalyst will it be for the stock if A2-73 is included in the ACTC in just a few short months?



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147095754



I would say at the minimum Paul Aisen will put what he knows of A2-73 on the table and just abstain from voting if there is a perceived conflict of interest.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147099090


Jimmy/Nidan....agree with the assessment that with Paul Aisen joined with Tayo Fadiran and Frederico Goodsaid who are alumni of FDA/CDER, we should have a good chance to be one of the ACTC's first picks.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147097692



What if Aisen is a going along with Biogen's trial for the sake of political harmony?

With the "side effect" of creating precedent for an Anavex trial that is similar?



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147411412



N.A. sites will have to be added under the ACTC because U.S. medical system's manner of diagnosing and treating Alzheimer's is too random.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147758282



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News